We are live on ! Find out more
OGEN icon

Oragenics
OGEN

7 hedge funds and large institutions have $3.06M invested in Oragenics in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% more ownership

Funds ownership: 0% → 0.02% (+0.02%)

33% less capital invested

Capital invested by funds: $4.58M → $3.06M (-$1.52M)

50% less funds holding

Funds holding: 14 → 7 (-7)

88% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 8

Holders
7
Holders Change
-7
Holders Change %
-50%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$55.4K
2
VF
Virtu Financial
New York
+$11.1K
3
Barclays
Barclays
United Kingdom
+$3.7K

Top Sellers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
-$405K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$22K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$21K
4
Citadel Advisors
Citadel Advisors
Florida
-$10K
5
Northern Trust
Northern Trust
Illinois
-$7K

OGEN Hedge Fund Activity: Q1 2018 in Review

7 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2018, worth a combined $3.06M — down 33% from $4.58M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of OGEN and 1 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was IFP Advisors, adding an estimated $55.4K. The largest seller was MSD Partners, exiting entirely with an estimated $405K sold.

  • 7 institutional investors held Oragenics (OGEN) as of Q1 2018, down from 14 in Q4 2017.
  • Funds reported $3.06M of Oragenics stock for Q1 2018, down 33% quarter-over-quarter.
  • 1 fund opened new Oragenics positions in Q1 2018 and 8 closed out, a net change of -7 holders.
  • The largest Oragenics buyer in Q1 2018 was IFP Advisors, an estimated $55.4K added.
  • The largest Oragenics seller in Q1 2018 was MSD Partners, an estimated $405K sold.

Based on aggregated 13F filings for Q1 2018.